[go: up one dir, main page]

ATE165598T1 - Heteroatom-substituierte liganden und metallkomplexe davon - Google Patents

Heteroatom-substituierte liganden und metallkomplexe davon

Info

Publication number
ATE165598T1
ATE165598T1 AT94108968T AT94108968T ATE165598T1 AT E165598 T1 ATE165598 T1 AT E165598T1 AT 94108968 T AT94108968 T AT 94108968T AT 94108968 T AT94108968 T AT 94108968T AT E165598 T1 ATE165598 T1 AT E165598T1
Authority
AT
Austria
Prior art keywords
metal complexes
heteroatom substituted
substituted ligands
heteroatom
complexes
Prior art date
Application number
AT94108968T
Other languages
English (en)
Inventor
Kondareddiar Ramalingam
Natarajan Raju
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22141146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE165598(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Application granted granted Critical
Publication of ATE165598T1 publication Critical patent/ATE165598T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT94108968T 1993-06-15 1994-06-10 Heteroatom-substituierte liganden und metallkomplexe davon ATE165598T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7798193A 1993-06-15 1993-06-15

Publications (1)

Publication Number Publication Date
ATE165598T1 true ATE165598T1 (de) 1998-05-15

Family

ID=22141146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94108968T ATE165598T1 (de) 1993-06-15 1994-06-10 Heteroatom-substituierte liganden und metallkomplexe davon

Country Status (19)

Country Link
US (5) US5608110A (de)
EP (1) EP0629617B2 (de)
JP (1) JP3835831B2 (de)
KR (1) KR100346795B1 (de)
CN (1) CN1055685C (de)
AT (1) ATE165598T1 (de)
AU (1) AU678001B2 (de)
CA (1) CA2125895C (de)
CZ (1) CZ295519B6 (de)
DE (1) DE69409870T3 (de)
DK (1) DK0629617T3 (de)
ES (1) ES2115805T3 (de)
FI (1) FI942795L (de)
HU (1) HU9401777D0 (de)
IL (1) IL109925A (de)
NO (1) NO305078B1 (de)
PL (1) PL303843A1 (de)
RU (1) RU94022254A (de)
ZA (1) ZA944201B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359120B1 (en) * 1991-10-29 2002-03-19 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia-localizing moiety
DE69326557T2 (de) * 1992-10-08 2000-01-05 Nycomed Amersham Plc, Little Chalfont Metall-oxim chelate zur verwendung als röntgenpharmazeutische wirkstoffe
US5811076A (en) 1993-05-20 1998-09-22 The Regents Of The University Of California Macromolecular contrast media for MR imaging
CA2168652A1 (en) * 1993-08-04 1995-02-16 Colin Mill Archer Radiometal complexes that localise in hypoxic tissue
IL111592A0 (en) * 1993-12-14 1995-01-24 Bracco Int Bv Stable multilayer lyophile
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
AU5676398A (en) * 1997-01-31 1998-08-25 University Of Alberta, The Method for detecting exogenous gene expression
US6004529A (en) 1997-04-11 1999-12-21 Nycomed Imaging As Chelating agents
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
NZ504372A (en) 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
RU2205186C2 (ru) * 1998-05-15 2003-05-27 Амершам Плк Меченые аналоги глутамина и лизина
JP3519302B2 (ja) 1999-02-09 2004-04-12 株式会社東海理化電機製作所 ウエビング巻取装置用プリテンショナー
US6465785B1 (en) * 2000-05-05 2002-10-15 Infrared Solutions, Inc. Apparatus and method for compensating for pixel non-uniformity in a bolometer
CA2410887C (en) 2000-06-02 2012-07-24 Bracco Research Usa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
CA2426584C (en) * 2000-10-19 2010-08-10 Bracco Research Usa Radiopharmaceutical formulations
WO2002062810A2 (en) * 2000-11-29 2002-08-15 Bracco International B.V. Linkable sialyl lewis x analogs
US6384232B1 (en) 2001-03-27 2002-05-07 Bracco International B.V. Methods of synthesizing heteroatom-bearing ligands and intermediate used thereof
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2003074005A2 (en) 2002-03-01 2003-09-12 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2003086563A2 (en) * 2002-04-11 2003-10-23 Carbomer, Inc. Diabetes imaging probes
ATE315562T1 (de) * 2002-09-25 2006-02-15 Daiso Co Ltd Verfahren zur herstellung von glycidylphthalimid
MXPA05005469A (es) * 2002-11-25 2005-09-08 Attenuon Llc Peptidos que inhibien angiogenesis, migracion celular, invasion celular y proliferacion celular, composiciones y usos de los mismos.
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
JP5466350B2 (ja) 2003-03-03 2014-04-09 ダイアックス、コープ ＨＧＦレセプター（ｃＭｅｔ）を特異的に結合するペプチドおよびその使用
SG177216A1 (en) * 2003-07-24 2012-01-30 Bracco Imaging Spa Stable radiopharmaceutical compositions and methods for their preparation
JP2008501624A (ja) * 2003-11-18 2008-01-24 アテニュオン， エルエルシー ウロキナーゼのアミノ末端断片と結合する抗体および／または抗体コンジュゲート、その組成物ならびに使用
WO2006039505A2 (en) 2004-09-30 2006-04-13 Molecular Devices Corporation Luminescent lanthanide complexes
KR100675356B1 (ko) * 2005-04-29 2007-02-01 경희대학교 산학협력단 액체 또는 초임계상태의 유체를 이용하여 금속이온 및금속산화물을 추출하는 금속추출에 사용되는 신규한 아미드화합물을 포함하는 킬레이트제와 상기 킬레이트제를이용한 금속추출방법 및 금속추출시스템
AU2007233155B2 (en) 2006-03-29 2012-04-26 Scitech Development Llc Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP2007297305A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
US8105602B2 (en) * 2006-12-08 2012-01-31 Tactic Pharma, Llc Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
EP2097438B1 (de) 2006-12-11 2015-08-26 Bracco Imaging S.p.A Fibrinbindende peptidkonjugate für diagnostische und therapeutische anwendungen
GB0804406D0 (en) * 2008-03-10 2008-04-16 Univ Zuerich Metal complexes
EP2147684A1 (de) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Selektiv gegen Metallproteasen wirkende Diagnosemittel
US20120045393A1 (en) 2009-03-17 2012-02-23 Linder Karen E Lhrh-ii peptide analogs
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
FR2989085A1 (fr) * 2012-04-05 2013-10-11 Commissariat Energie Atomique Radiotraceurs, procedes de preparation et applications
WO2015171543A1 (en) 2014-05-05 2015-11-12 California Institute Of Technology Mutant akt-specific capture agents, compositions, and methods of using and making
CN108290927B (zh) 2015-07-15 2022-06-24 加州理工学院 Il-17f-特异性捕获剂、组合物以及使用和制造的方法
KR102686073B1 (ko) 2015-10-14 2024-07-17 엑스-써마 인코포레이티드 얼음 결정 형성을 감소시키기 위한 조성물 및 방법
JP6991148B2 (ja) 2016-02-09 2022-01-12 ブラッコ・スイス・ソシエテ・アノニム セレクチン標的化のための組み換えキメラタンパク質
WO2017176769A1 (en) 2016-04-04 2017-10-12 Indi Molecular, Inc. Cd8-specific capture agents, compositions, and methods of using and making
US9643939B1 (en) 2016-04-18 2017-05-09 Optimus Drugs Private Limited Process for the preparation of linezolid
USRE47606E1 (en) 2016-04-21 2019-09-17 Optimus Drugs Private Limited Process for the preparation of linezolid
ES3002745T3 (en) 2016-07-06 2025-03-07 Univ Michigan Regents Multifunctional inhibitors of mek/pi3k and mtor/mek/pi3k biological pathways and therapeutic methods using the same
EP3519425B1 (de) 2016-09-29 2024-02-28 Indi Molecular, Inc. Zusammensetzungen zum nachweis, zur hemmung und zur bildgebung von indolamin 2,3-dioxygenase 1 (ido1) und verfahren zur herstellung und verwendung davon
WO2018085375A1 (en) 2016-11-01 2018-05-11 Ohio State Innovation Foundation Methods for the iodination of biomolecules
US11174368B2 (en) * 2016-11-09 2021-11-16 Kuraray Co., Ltd. Oxygen absorbing agent
EP3638687A1 (de) 2017-06-15 2020-04-22 Indi Molecular, Inc. Il-17f- und il-17a-spezifische fänger, zusammensetzungen und verfahren zur verwendung und herstellung davon
WO2019093699A1 (ko) * 2017-11-09 2019-05-16 서울대학교 산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
KR102083180B1 (ko) * 2017-11-09 2020-03-02 서울대학교산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법, 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
CN112041293B (zh) * 2018-04-19 2023-10-20 株式会社可乐丽 含不饱和双键化合物、使用了该化合物的氧吸收剂、以及树脂组合物
IL271681A (en) 2018-07-18 2020-01-30 Vyripharm Entpr Llc Systems and methods for integrated and comprehensive management of cannabis products
WO2020097531A1 (en) 2018-11-08 2020-05-14 Indi Molecular, Inc. Theranostic capture agents, compositions, and methods of using and making
US20200291391A1 (en) 2019-03-12 2020-09-17 Indi Molecular, Inc. Cross-linked epitopes and methods of use thereof
EP3972646A4 (de) 2019-05-20 2023-06-14 Ohio State Innovation Foundation Apohämoglobin-haptoglobin-komplexe und verfahren zur verwendung davon
WO2020236969A1 (en) 2019-05-20 2020-11-26 Indi Molecular, Inc. Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
WO2022098745A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, delivery systems, and methods useful in tumor therapy
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
IL309839A (en) 2021-07-26 2024-02-01 Arvinas Operations Inc Methods for producing a bifunctional compound
CN114907562B (zh) * 2022-01-29 2023-08-18 华东理工大学 β-内酰胺单体的合成及聚合方法
WO2024258974A1 (en) * 2023-06-12 2024-12-19 Regents Of The University Of Minnesota Ligands and complexes and uses thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3369121A (en) * 1966-04-06 1968-02-13 Squibb & Sons Inc Radioactive package and container therefor
US3920995A (en) * 1973-05-04 1975-11-18 Squibb & Sons Inc Radioactive material generator
US4071613A (en) * 1976-02-26 1978-01-31 Abbott Laboratories Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
JPS54126597A (en) * 1978-03-02 1979-10-01 Radiochemical Centre Ltd Method of and device for fabricating diagnostic scan agent
US4193979A (en) * 1978-05-22 1980-03-18 G. D. Searle & Co. Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]carbonyl]-2-pyridinecarboxylic acid and related compounds labeled with technetium-99m
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4363793A (en) * 1979-08-30 1982-12-14 State University Of New York Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues
GB2093451B (en) * 1981-02-24 1984-10-31 May & Baker Ltd Nitroimidazole derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
US4462992A (en) * 1982-02-08 1984-07-31 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4758682A (en) * 1983-03-17 1988-07-19 California Institute Of Technology Homogeneous coordination compounds as oxidation catalysts
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
GB8426845D0 (en) * 1984-10-24 1984-11-28 Amersham Int Plc Complexes of technetium-99m
JPS61103841A (ja) * 1984-10-26 1986-05-22 Nippon Mejifuijitsukusu Kk 放射性テクネチウム標識に供する安定な塩化第一スズ組成物
EP0194843B1 (de) * 1985-03-11 1993-01-13 AMERSHAM INTERNATIONAL plc Komplexe von Technetium-99m mit Propylen-Amin-Oximen
US5187264A (en) * 1986-05-28 1993-02-16 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
ATE52516T1 (de) * 1986-05-28 1990-05-15 Mallinckrodt Inc Technetiumchelate fuer die bestimmung der nierenfunktion.
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5071636A (en) * 1987-12-29 1991-12-10 Nihon Medi-Physics Co., Ltd. Chelating compounds and their use
WO1989010759A1 (en) * 1988-04-29 1989-11-16 Mallinckrodt, Inc. Diaminedithiol chelating agents for radiopharmaceuticals
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5089249A (en) * 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
US5026829A (en) * 1989-01-23 1991-06-25 University Of Cincinnati Cyclo substituted propyleneamine oxime and its use as a brain imaging agent
US4895960A (en) * 1989-01-23 1990-01-23 University Of Cincinnati Cyclo substituted propyleneamine oxime and its use as a brain imaging agent
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
CN1022562C (zh) * 1989-04-08 1993-10-27 中国人民解放军第二军医大学 一种消瘤药——甲硝唑氨酸的合成方法
US5101041A (en) * 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
US5164176A (en) * 1989-06-16 1992-11-17 Neorx Corporation Radionuclide metal chelates for the radiolabeling of proteins
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
CA2034042C (en) * 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
DK0532566T3 (da) * 1990-06-01 1995-07-31 Inst F R Diagnostikforschung G Cyklopentadienylcarbonyl-99mTc-komplekser, fremgangsmåde til fremstilling af disse samt deres anvendelse i diagnostikken
DE4025788C2 (de) * 1990-08-10 1994-04-14 Diagnostikforschung Inst Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung sowie deren Verwendung in Diagnostik und Therapie
US5116598A (en) * 1990-10-29 1992-05-26 Mallinckrodt Medical, Inc. N4 technetium-99 m complexes for use as radiopharmaceuticals
US5037631A (en) * 1990-10-29 1991-08-06 Mallinckrodt Medical, Inc. Technetium-99M complex for examinating the renal function
US5104638A (en) * 1990-10-29 1992-04-14 Mallinckrodt Medical, Inc. Method of making a radiopharmaceutical complex from a kit
GB9028105D0 (en) * 1990-12-27 1991-02-13 Erba Carlo Spa Process for the preparation of substituted benzofuran derivatives
JP2703408B2 (ja) * 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
DE4107571A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Amid-chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
IL103353A (en) * 1991-10-29 1999-01-26 Bracco Int Bv His metal bracelet ligand is a diagnostic product and processes for its preparation
DE69326557T2 (de) * 1992-10-08 2000-01-05 Nycomed Amersham Plc, Little Chalfont Metall-oxim chelate zur verwendung als röntgenpharmazeutische wirkstoffe
EP0618191A1 (de) * 1993-04-02 1994-10-05 AMERSHAM INTERNATIONAL plc Metall-chelatierende Verbindungen

Also Published As

Publication number Publication date
ES2115805T3 (es) 1998-07-01
AU6467294A (en) 1994-12-22
DE69409870T2 (de) 1998-12-10
US5665329A (en) 1997-09-09
CA2125895A1 (en) 1994-12-16
NO305078B1 (no) 1999-03-29
FI942795A0 (fi) 1994-06-13
CN1099388A (zh) 1995-03-01
RU94022254A (ru) 1996-04-20
DE69409870T3 (de) 2008-03-13
HU9401777D0 (en) 1994-09-28
NO942231D0 (no) 1994-06-14
FI942795L (fi) 1994-12-16
AU678001B2 (en) 1997-05-15
EP0629617A1 (de) 1994-12-21
PL303843A1 (en) 1994-12-27
CA2125895C (en) 2000-03-14
CN1055685C (zh) 2000-08-23
CZ295519B6 (cs) 2005-08-17
US5627286A (en) 1997-05-06
EP0629617B2 (de) 2007-09-26
KR100346795B1 (ko) 2002-11-29
DK0629617T3 (da) 1998-10-07
JP3835831B2 (ja) 2006-10-18
NO942231L (no) 1994-12-16
IL109925A (en) 2005-12-18
IL109925A0 (en) 1994-10-07
US5656254A (en) 1997-08-12
ZA944201B (en) 1995-02-08
JPH0789922A (ja) 1995-04-04
US5741912A (en) 1998-04-21
CZ145594A3 (en) 1995-05-17
DE69409870D1 (de) 1998-06-04
US5608110A (en) 1997-03-04
EP0629617B1 (de) 1998-04-29
KR950000671A (ko) 1995-01-03

Similar Documents

Publication Publication Date Title
ATE165598T1 (de) Heteroatom-substituierte liganden und metallkomplexe davon
FI946157L (fi) Polyaminoituja ligandeja ja niiden metallikomplekseja
ATE156838T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren 5-alpha-reduktases
DE68916345D1 (de) Thermit-Überzug.
DE68908273D1 (de) Metal radionukleid-chelatverbindungen mit verbesserter chelatierungskinetik.
DK137989D0 (da) Overgangsmetalforbindelser
DE68906740D1 (de) Metallische zusammensetzung enthaltend zinkoxyd-whisker.
FI960849A0 (fi) Metallikomplekseja sisältäviä farmaseuttisia koostumuksia
ATE84537T1 (de) Neue titankatalysatoren.
ATE158300T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-cholestan-on n als inhibitoren 5-alpha-reduktases
DE3482119D1 (de) Metallkomplexe.
DE69114986D1 (de) Eine Phosphino-Binapthyl-Verbindung und Übergangsmetall-Komplexe davon.
DE69432022D1 (de) Polyazacycloalkane als doppelte chelatbildner
FI943452L (fi) Organosiloksaanisidotut transitiometallikompleksit
ES2099900T3 (es) Procedimiento para la preparacion de complejos con metales de derivados de n-beta-hidroxialquil-tri-n-carboxialquil-1,4,7,10-tetraaza-ciclododecanos y de n-beta-hidroxialquil-tri-n-carboxialquil-1,4,8,11-tetraaza-ciclotetradecanos.
DE69129446D1 (de) Bestimmung der Zusammensetzung von Metallschmelzen
FI932035A0 (fi) Tricykliska foereningar innehaollande heteroatomer
DE58908552D1 (de) Übergangsmetallkomplexe.
DE3685284D1 (de) Chlorieren von eisenhaltigen metallstoffen.
DE69200351D1 (de) Verfahren zur Direktnitridierung von Metallen mit niedrigem Schmelzpunkt.
NO892189D0 (no) Trijodbenzenforbindelser og kontrastmidler for radiografiinneholdende disse.
FI901546A0 (fi) Kompositioner innehaollande 2-tiocyanometyltiobensotiazol foer anvaendning i industriella mikrobiocider.
DK472085D0 (da) Metalcomplexer af bis-indolforbindelser
KR890013197A (ko) 함크롬 용철의 제조방법
NO923118L (no) Metallisk spindelpakning

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee